ExxonMobil modifies facilities to produce medical-grade sanitizer for COVID-19 response

IRVING, Texas – ExxonMobil said today it has reconfigured manufacturing operations in Louisiana to produce medical-grade hand sanitizer for donation to COVID-19 response efforts in Louisiana, New Jersey, New Mexico, New York, Pennsylvania and Texas.

News April 24, 2020

ExxonMobil modifies facilities to produce medical-grade sanitizer for COVID-19 response
  • Product to be donated to health care providers and first responders across the United States
  • Equipment modified to enable Baton Rouge area facilities to produce, blend, package and distribute sanitizer 
  • Targeting production of 160,000 gallons of sanitizer, enough for nearly 5 million bottles

Initial production of 160,000 gallons of medical grade sanitizer – enough to fill nearly 5 million 4-ounce bottles – is being distributed to medical providers and first responders. Additional donation locations are planned.

“The ingenuity and dedication of our employees to develop a consumer-ready product in record time demonstrates ExxonMobil’s commitment to help those in need during the global pandemic,” said Darren Woods, chairman and chief executive officer of Exxon Mobil Corporation. “We’re focused on keeping our people and communities safe while supporting frontline responders and meeting customer needs.” 

ExxonMobil has increased monthly production of isopropyl alcohol -- a key ingredient in sanitizer – by about 3,000 tonnes at its chemical manufacturing facility in Baton Rouge, Louisiana. To produce, package and distribute hand sanitizer, the company purchased additional ingredients and modified equipment in Baton Rouge and at a lubricants plant in nearby Port Allen, Louisiana. 

“To stand up an entirely new process and supply chain in a matter of weeks, while maintaining ExxonMobil’s high standards for safety and quality and in compliance with FDA requirements is truly remarkable,” said Karen McKee, president of ExxonMobil Chemical Company. 

Earlier this month, ExxonMobil announced the increased production of isopropyl alcohol, which is enough to enable monthly production of up to 50 million 4-ounce bottles of sanitizer. The company also increased its capability to manufacture specialized polypropylene, used in medical masks and gowns, by about 1,000 tonnes per month, which is enough to enable production of up to 200 million medical masks or 20 million gowns.

ExxonMobil is also participating in a technology collaboration with the Global Center for Medical Innovation to rapidly redesign and manufacture reusable personal protection equipment, such as medical face shields and masks.  

About ExxonMobil

ExxonMobil, one of the largest publicly traded international energy companies, uses technology and innovation to help meet the world’s growing energy needs. ExxonMobil holds an industry-leading inventory of resources, is one of the largest refiners and marketers of petroleum products, and its chemical company is one of the largest in the world. To learn more, visit exxonmobil.com and the Energy Factor

Follow us on Twitter and LinkedIn

Cautionary Statement: Statements of future events or conditions in this release are forward-looking statements. Actual future results, our production capacity, and the impact of the COVID-19 pandemic on ExxonMobil’s business and results could vary significantly depending on a number of factors including the supply and demand for oil, gas, and petroleum products and other market factors affecting oil, gas, petrochemical and feedstock prices; the outcome of government policies and actions, including actions taken to address COVID-19 and to maintain the functioning of national and global economies and markets; the severity, length and ultimate impact of COVID-19 on people and economies; the outcome of further research and testing; the development and competitiveness of alternative technologies; the impact of company actions to protect the health and safety of employees, vendors, customers, and communities; actions of competitors and commercial counterparties; the ability to scale pilot projects on a cost-effective basis; political and regulatory developments including actions that may favor certain types of technologies over others; the outcome of commercial negotiations; and other factors discussed under Item 1A Risk Factors in ExxonMobil’s most recent annual report on Form 10-K and set forth under the heading “Factors Affecting Future Results” on the Investors page of our website at exxonmobil.com.

Public Company Information: NYSE: XOM

Contact: Media Line (972) 940-6007